Data as of Oct 21
| +0.06 / +0.76%|
The 5 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 13.00 and a low estimate of 8.00. The median estimate represents a +12.50% increase from the last price of 8.00.
The current consensus among 5 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.